Safety of Intravenous Immunoglobulin (Tegeline®), Administered at Home in Patients with Autoimmune Disease: Results of a French Study

The efficacy of intravenous immunoglobulins (IVIg) in patients with autoimmune diseases (AID) has been known for several decades. Majority of these patients received IVIg in hospital. A retrospective study was conducted in 22 centers in France to evaluate the feasibility of the administration of Teg...

Descripción completa

Detalles Bibliográficos
Autores principales: Hachulla, Eric, Le Masson, Gwendal, Solé, Guilhem, Hamidou, Mohamed, Desnuelle, Claude, Azulay, Jean-Philippe, Besson, Gérard, Swiader, Laure, Abad, Sébastien, Antoine, Jean-Christophe, Bouhour, Françoise, Créange, Alain, Grenouillet, Marike, Magy, Laurent, Marcel, Sébastien, Paquet, Jean-Michel, Rouhart, François, Ziegler, François, Mathis, Stéphane, Gauthier-Darnis, Marc, Puget, Sophie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5875056/
https://www.ncbi.nlm.nih.gov/pubmed/29736397
http://dx.doi.org/10.1155/2018/8147251

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5875056/
https://www.ncbi.nlm.nih.gov/pubmed/29736397
http://dx.doi.org/10.1155/2018/8147251

Ejemplares similares